Literature DB >> 26235028

Structure and Assembly Mechanism of the Signaling Complex Mediated by Human CSF-1.

Jan Felix1, Steven De Munck1, Kenneth Verstraete1, Leander Meuris2, Nico Callewaert2, Jonathan Elegheert3, Savvas N Savvides4.   

Abstract

Human colony-stimulating factor 1 receptor (hCSF-1R) is unique among the hematopoietic receptors because it is activated by two distinct cytokines, CSF-1 and interleukin-34 (IL-34). Despite ever-growing insights into the central role of hCSF-1R signaling in innate and adaptive immunity, inflammatory diseases, and cancer, the structural basis of the functional dichotomy of hCSF-1R has remained elusive. Here, we report crystal structures of ternary complexes between hCSF-1 and hCSF-1R, including their complete extracellular assembly, and propose a mechanism for the cooperative human CSF-1:CSF-1R complex that relies on the adoption by dimeric hCSF-1 of an active conformational state and homotypic receptor interactions. Furthermore, we trace the cytokine-binding duality of hCSF-1R to a limited set of conserved interactions mediated by functionally equivalent residues on CSF-1 and IL-34 that play into the geometric requirements of hCSF-1R activation, and map the possible mechanistic consequences of somatic mutations in hCSF-1R associated with cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26235028     DOI: 10.1016/j.str.2015.06.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  10 in total

Review 1.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

Review 2.  Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Authors:  Jan Felix; Savvas N Savvides
Journal:  Nat Rev Immunol       Date:  2016-12-28       Impact factor: 53.106

Review 3.  Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance.

Authors:  Astik Priya; Shivani Yadav; Diksha R Borade; Reena Agrawal-Rajput
Journal:  Immunol Res       Date:  2022-10-21       Impact factor: 4.505

Review 4.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

5.  Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity.

Authors:  Sam Detry; Julie Andries; Yehudi Bloch; Cem Gabay; Danielle M Clancy; Savvas N Savvides
Journal:  J Biol Chem       Date:  2022-04-06       Impact factor: 5.486

6.  IL-34 Upregulated Th17 Production through Increased IL-6 Expression by Rheumatoid Fibroblast-Like Synoviocytes.

Authors:  Bing Wang; Zijian Ma; Miaomiao Wang; Xiaotong Sun; Yawei Tang; Ming Li; Yan Zhang; Fang Li; Xia Li
Journal:  Mediators Inflamm       Date:  2017-06-04       Impact factor: 4.711

7.  Homogeneously N-glycosylated proteins derived from the GlycoDelete HEK293 cell line enable diffraction-quality crystallogenesis.

Authors:  Sandra Kozak; Yehudi Bloch; Steven De Munck; Aleksandra Mikula; Isabel Bento; Savvas N Savvides; Rob Meijers
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-11-24       Impact factor: 7.652

8.  Attenuated CSF-1R signalling drives cerebrovascular pathology.

Authors:  Conor Delaney; Michael Farrell; Colin P Doherty; Kiva Brennan; Eoin O'Keeffe; Chris Greene; Kieva Byrne; Eoin Kelly; Niamh Birmingham; Paula Hickey; Simon Cronin; Savvas N Savvides; Sarah L Doyle; Matthew Campbell
Journal:  EMBO Mol Med       Date:  2020-12-22       Impact factor: 12.137

9.  A dual-specific macrophage colony-stimulating factor antagonist of c-FMS and αvβ3 integrin for osteoporosis therapy.

Authors:  Yuval Zur; Lior Rosenfeld; Chen Anna Keshelman; Nofar Dalal; Gali Guterman-Ram; Ayelet Orenbuch; Yulia Einav; Noam Levaot; Niv Papo
Journal:  PLoS Biol       Date:  2018-08-24       Impact factor: 8.029

Review 10.  Immunomodulation of Interleukin-34 and its Potential Significance as a Disease Biomarker and Therapeutic Target.

Authors:  Yun Ge; Man Huang; Yong-Ming Yao
Journal:  Int J Biol Sci       Date:  2019-07-20       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.